S. Batra et al., POTENTIATION BY ESTRAMUSTINE OF THE CYTOTOXIC EFFECT OF VINBLASTINE AND DOXORUBICIN IN PROSTATIC TUMOR-CELLS, International journal of cancer, 68(5), 1996, pp. 644-649
The effects of combining estramustine (EM) with vinblastine (VLB) or d
oxorubicin (DOX) on cellular uptake, cellular retention and cell survi
val were investigated in Dunning hormone-insensitive rat prostate AT-I
tumor cells and DU-145 human prostatic tumor cells. Accumulation of V
LB and DOX by AT-I cells was less than one-half of that in DU-145 cell
s. Inclusion of EM or estromustine considerably increased uptake of bo
th VLB and DOX in AT-I cells but not in DU-145 cells. Verapamil and ta
moxifen also potentiated VLB uptake in AT-I cells. A combination of VL
B and EM resulted in a considerable synergistic effect on both cytotox
icity and cellular retention of VLB. The presence of P-glycoprotein (P
gp) in AT-I cells could be demonstrated by both Western blots and immu
nocytochemical detection. Photoaffinity labeling of Pgp by [H-3]-azido
pine was clearly inhibited by VLB, verapamil and EM. Our data strongly
support the argument for a combination of EM with not only VLB but al
so DOX to improve the therapeutic index in patients with prostate canc
er. (C) 1996 Wiley-Liss, Inc.